Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Blood|August 28, 2009
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremiaEnrico Brunetta, Manuela Fogli, Stefania Varchetta, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 8, 2013
Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and functionElisa Montaldo, Genny Del Zotto, Mariella Della Chiesa, et al.
Plos One|June 23, 2012
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune responseBarbara Morandi, Lorenzo Mortara, Laura Chiossone, et al.
Structure (London, England : 1993)|June 7, 2003
The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicityClaudia Cantoni, Marco Ponassi, Roberto Biassoni, et al.
Plos One|October 18, 2007
Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiencyJacques Zimmer, Huguette Bausinger, Emmanuel Andrès, et al.
European Journal of Immunology|July 20, 2004
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patientsManuela Fogli, Paola Costa, Giuseppe Murdaca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolyticGuido Ferlazzo, Dolca Thomas, Shao-Lee Lin, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Blood|August 28, 2009
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremiaEnrico Brunetta, Manuela Fogli, Stefania Varchetta, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 8, 2013
Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and functionElisa Montaldo, Genny Del Zotto, Mariella Della Chiesa, et al.
Plos One|June 23, 2012
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune responseBarbara Morandi, Lorenzo Mortara, Laura Chiossone, et al.
Structure (London, England : 1993)|June 7, 2003
The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicityClaudia Cantoni, Marco Ponassi, Roberto Biassoni, et al.
Plos One|October 18, 2007
Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiencyJacques Zimmer, Huguette Bausinger, Emmanuel Andrès, et al.
European Journal of Immunology|July 20, 2004
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patientsManuela Fogli, Paola Costa, Giuseppe Murdaca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolyticGuido Ferlazzo, Dolca Thomas, Shao-Lee Lin, et al.
Pageof 21